-
Something wrong with this record ?
Mitochondrial ROS Triggers KIN Pathogenesis in FAN1-Deficient Kidneys
M. Airik, H. Arbore, E. Childs, AB. Huynh, YL. Phua, CW. Chen, K. Aird, S. Bharathi, B. Zhang, P. Conlon, S. Kmoch, K. Kidd, AJ. Bleyer, J. Vockley, E. Goetzman, P. Wipf, R. Airik
Status not-indexed Language English Country Switzerland
Document type Journal Article
Grant support
DK115403
NIDDK NIH HHS - United States
NLK
Directory of Open Access Journals
from 2012
PubMed Central
from 2012
Europe PubMed Central
from 2012
ProQuest Central
from 2012-03-01
Open Access Digital Library
from 2012-01-01
Open Access Digital Library
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2012
- Publication type
- Journal Article MeSH
Karyomegalic interstitial nephritis (KIN) is a genetic adult-onset chronic kidney disease (CKD) characterized by genomic instability and mitotic abnormalities in the tubular epithelial cells. KIN is caused by recessive mutations in the FAN1 DNA repair enzyme. However, the endogenous source of DNA damage in FAN1/KIN kidneys has not been identified. Here we show, using FAN1-deficient human renal tubular epithelial cells (hRTECs) and FAN1-null mice as a model of KIN, that FAN1 kidney pathophysiology is triggered by hypersensitivity to endogenous reactive oxygen species (ROS), which cause chronic oxidative and double-strand DNA damage in the kidney tubular epithelial cells, accompanied by an intrinsic failure to repair DNA damage. Furthermore, persistent oxidative stress in FAN1-deficient RTECs and FAN1 kidneys caused mitochondrial deficiencies in oxidative phosphorylation and fatty acid oxidation. The administration of subclinical, low-dose cisplatin increased oxidative stress and aggravated mitochondrial dysfunction in FAN1-deficient kidneys, thereby exacerbating KIN pathophysiology. In contrast, treatment of FAN1 mice with a mitochondria-targeted ROS scavenger, JP4-039, attenuated oxidative stress and accumulation of DNA damage, mitigated tubular injury, and preserved kidney function in cisplatin-treated FAN1-null mice, demonstrating that endogenous oxygen stress is an important source of DNA damage in FAN1-deficient kidneys and a driver of KIN pathogenesis. Our findings indicate that therapeutic modulation of kidney oxidative stress may be a promising avenue to mitigate FAN1/KIN kidney pathophysiology and disease progression in patients.
Department of Chemistry University of Pittsburgh Pittsburgh PA 15260 USA
Department of Developmental Biology University of Pittsburgh Pittsburgh PA 15224 USA
Nephrology Department Beaumont Hospital D09 V2N0 Dublin Ireland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010028
- 003
- CZ-PrNML
- 005
- 20230721095345.0
- 007
- ta
- 008
- 230707s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/antiox12040900 $2 doi
- 035 __
- $a (PubMed)37107275
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Airik, Merlin $u Division of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA
- 245 10
- $a Mitochondrial ROS Triggers KIN Pathogenesis in FAN1-Deficient Kidneys / $c M. Airik, H. Arbore, E. Childs, AB. Huynh, YL. Phua, CW. Chen, K. Aird, S. Bharathi, B. Zhang, P. Conlon, S. Kmoch, K. Kidd, AJ. Bleyer, J. Vockley, E. Goetzman, P. Wipf, R. Airik
- 520 9_
- $a Karyomegalic interstitial nephritis (KIN) is a genetic adult-onset chronic kidney disease (CKD) characterized by genomic instability and mitotic abnormalities in the tubular epithelial cells. KIN is caused by recessive mutations in the FAN1 DNA repair enzyme. However, the endogenous source of DNA damage in FAN1/KIN kidneys has not been identified. Here we show, using FAN1-deficient human renal tubular epithelial cells (hRTECs) and FAN1-null mice as a model of KIN, that FAN1 kidney pathophysiology is triggered by hypersensitivity to endogenous reactive oxygen species (ROS), which cause chronic oxidative and double-strand DNA damage in the kidney tubular epithelial cells, accompanied by an intrinsic failure to repair DNA damage. Furthermore, persistent oxidative stress in FAN1-deficient RTECs and FAN1 kidneys caused mitochondrial deficiencies in oxidative phosphorylation and fatty acid oxidation. The administration of subclinical, low-dose cisplatin increased oxidative stress and aggravated mitochondrial dysfunction in FAN1-deficient kidneys, thereby exacerbating KIN pathophysiology. In contrast, treatment of FAN1 mice with a mitochondria-targeted ROS scavenger, JP4-039, attenuated oxidative stress and accumulation of DNA damage, mitigated tubular injury, and preserved kidney function in cisplatin-treated FAN1-null mice, demonstrating that endogenous oxygen stress is an important source of DNA damage in FAN1-deficient kidneys and a driver of KIN pathogenesis. Our findings indicate that therapeutic modulation of kidney oxidative stress may be a promising avenue to mitigate FAN1/KIN kidney pathophysiology and disease progression in patients.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Arbore, Haley $u Division of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA
- 700 1_
- $a Childs, Elizabeth $u Division of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA
- 700 1_
- $a Huynh, Amy B $u Division of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA
- 700 1_
- $a Phua, Yu Leng $u Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA $1 https://orcid.org/0000000234288669
- 700 1_
- $a Chen, Chi Wei $u Department of Pharmacology & Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA $1 https://orcid.org/000000018658055X
- 700 1_
- $a Aird, Katherine $u Department of Pharmacology & Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA
- 700 1_
- $a Bharathi, Sivakama $u Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA
- 700 1_
- $a Zhang, Bob $u Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA
- 700 1_
- $a Conlon, Peter $u Nephrology Department, Beaumont Hospital, D09 V2N0 Dublin, Ireland
- 700 1_
- $a Kmoch, Stanislav $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, 128 08 Prague, Czech Republic
- 700 1_
- $a Kidd, Kendrah $u Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
- 700 1_
- $a Bleyer, Anthony J $u Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
- 700 1_
- $a Vockley, Jerry $u Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA
- 700 1_
- $a Goetzman, Eric $u Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA
- 700 1_
- $a Wipf, Peter $u Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA $1 https://orcid.org/0000000176935863
- 700 1_
- $a Airik, Rannar $u Division of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA $u Department of Developmental Biology, University of Pittsburgh, Pittsburgh, PA 15224, USA
- 773 0_
- $w MED00200130 $t Antioxidants (Basel, Switzerland) $x 2076-3921 $g Roč. 12, č. 4 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37107275 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230721095338 $b ABA008
- 999 __
- $a ok $b bmc $g 1958607 $s 1196292
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 12 $c 4 $e 20230408 $i 2076-3921 $m Antioxidants $n Antioxidants $x MED00200130
- GRA __
- $a DK115403 $p NIDDK NIH HHS $2 United States
- LZP __
- $a Pubmed-20230707